epirubicin; pidorubicin (Ellence)
Jump to navigation
Jump to search
Introduction
Tradename: Ellence.
Indications
- axillary node involvement after resection of breast cancer
- Hodgkin's disease
- diffuse large B-cell lymphoma
- gastric cancer
- osteosarcoma[2]
Adverse effects
Mechanism of action
More general terms
Component of
References
- ↑ Kaiser Permanente Northern California Drug Information, 2000
- ↑ Jump up to: 2.0 2.1 Deprecated Reference
- ↑ Jump up to: 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015